We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has approved label changes for general anesthetic and sedation drugs given to children younger than 3 years old because of the possible risks to their brain development. Read More
More than a dozen states are considering drug price transparency bills — most recently in California, where a state senate committee voted to advance legislation requiring drugmakers to disclose operating costs. Read More